Faculty profile

Anick Bérard

ResearcherMedicineMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.

Anick Bérard

Researcher

Medicine

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
8 publications in the last five years, latest in 2025.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 5 research grants (5 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Comparative Effectiveness And Safety Confounding Bias Exposure Measurement Errors Pharmacoepidemiology Prospective Studies Accelerating Clinical Trials Equity, Diversity And Inclusion Implementation Science

Latest papers

Obstetric mode of delivery and risk of attention deficit hyperactivity disorder in children: insights from the Quebec pregnancy cohort.
BMC pregnancy and childbirth · 2025 · senior author
Teratogenic Risk Impact Mitigation (TRIM): Development of Explicit Criteria to Facilitate Decisions Regarding Teratogenic Risk Mitigation Strategies.
Drug safety · 2025
Trends of antiseizure medication utilization among pregnant people in four Canadian provinces from 1998 to 2023; a study from the Canadian mother-child cohort active surveillance initiative (CAMCCO).
Frontiers in pharmacology · 2024

All 17 publications

Latest funding

PREGTRIAL (Inclusion of PREgnant and lactatinG people in clinical TRIALs)
CIHR · 2024 · Principal investigator
$598,561
New statistical methods for population-based studies of time-varying drug exposures: development, validation, and real-world analyses of drug safety and effectiveness
CIHR · 2021 · Co-investigator
$481,950
The "Atrial FIBrillation in Pregnancy: assessing seveRe matErnal morbidity and anticoagulation strateGies" (AFIB-PREG) Study
CIHR · 2021 · Principal investigator
$275,400

All 7 grants and awards

17 publications.

Obstetric mode of delivery and risk of attention deficit hyperactivity disorder in children: insights from the Quebec pregnancy cohort.

Sheehy O, Ferroum M, Gorgui J, Zhao JP, Berard A

BMC pregnancy and childbirth2025Senior author

DOI: 10.1186/s12884-025-07687-w PMID: 40442672

Teratogenic Risk Impact Mitigation (TRIM): Development of Explicit Criteria to Facilitate Decisions Regarding Teratogenic Risk Mitigation Strategies.

Ewig CLY, Wang Y, Smolinski NE, Toyserkani GA, LaCivita C, Lackey L, Eggers S, Sahin L, Abu-Rustum RS, Bateman BT, Berard A, Chambers CD, Choby B, Conover EA, Greene MF, Hernández-Díaz S, Jamieson DJ, Običan SG, Polifka JE, Roussos-Ross K, Sheffield JS, Lavigne SV, Zimmermann EM, Laffan SB, DeLise AM, Gilsenan AW, Hammad TA, Hampp C, Hardy JR, Knox CA, Shields K, Smith MY, Sobel RE, Tassinari MS, Maro JC, Rasmussen SA, Winterstein AG

Drug safety2025

DOI: 10.1007/s40264-025-01581-2 PMID: 40762949

Trends of antiseizure medication utilization among pregnant people in four Canadian provinces from 1998 to 2023; a study from the Canadian mother-child cohort active surveillance initiative (CAMCCO).

Peymani P, Berard A, Winquist B, Kaul P, Sheehy O, Lavu A, Leong C, Falk J, Delaney JA, Kowalec K, Ng M, Ruth C, Aboulatta L, Alessi-Severini S, Dragan R, Derksen S, Barrett O, Shams G, Eltonsy S

Frontiers in pharmacology2024

DOI: 10.3389/fphar.2024.1469552 PMID: 39600367

Causality assessment of adverse drug reaction: A narrative review to find the most exhaustive and easy-to-use tool in post-authorization settings.

Pradhan P, Lavallee M, Akinola S, Escobar Gimenes FR, Berard A, Methot J, Piche ME, Gonella JM, Cloutier L, Leclerc J

Journal of applied biomedicine2023

DOI: 10.32725/jab.2023.010 PMID: 37376882

Drug-related risk of hospital readmission in children with chronic diseases, a systematic review.

Jaberi E, Kassai B, Berard A, Grenet G, Nguyen KA

Therapie2023

DOI: 10.1016/j.therap.2022.09.004 PMID: 36192191

Changes in preterm birth and stillbirth during COVID-19 lockdowns in 26 countries.

Calvert C, Brockway MM, Zoega H, Miller JE, Been JV, Amegah AK, Racine-Poon A, Oskoui SE, Abok II, Aghaeepour N, Akwaowo CD, Alshaikh BN, Ayede AI, Bacchini F, Barekatain B, Barnes R, Bebak K, Berard A, Bhutta ZA, Brook JR, Bryan LR, Cajachagua-Torres KN, Campbell-Yeo M, Chu DT, Connor KL, Cornette L, Cortés S, Daly M, Debauche C, Dedeke IOF, Einarsdóttir K, Engjom H, Estrada-Gutierrez G, Fantasia I, Fiorentino NM, Franklin M, Fraser A, Gachuno OW, Gallo LA, Gissler M, Håberg SE, Habibelahi A, Häggström J, Hookham L, Hui L, Huicho L, Hunter KJ, Huq S, Kc A, Kadambari S, Kelishadi R, Khalili N, Kippen J, Le Doare K, Llorca J, Magee LA, Magnus MC, Man KKC, Mburugu PM, Mediratta RP, Morris AD, Muhajarine N, Mulholland RH, Bonnard LN, Nakibuuka V, Nassar N, Nyadanu SD, Oakley L, Oladokun A, Olayemi OO, Olutekunbi OA, Oluwafemi RO, Ogunkunle TO, Orton C, Örtqvist AK, Ouma J, Oyapero O, Palmer KR, Pedersen LH, Pereira G, Pereyra I, Philip RK, Pruski D, Przybylski M, Quezada-Pinedo HG, Regan AK, Rhoda NR, Rihs TA, Riley T, Rocha TAH, Rolnik DL, Saner C, Schneuer FJ, Souter VL, Stephansson O, Sun S, Swift EM, Szabó M, Temmerman M, Tooke L, Urquia ML, von Dadelszen P, Wellenius GA, Whitehead C, Wong ICK, Wood R, Wróblewska-Seniuk K, Yeboah-Antwi K, Yilgwan CS, Zawiejska A, Sheikh A, Rodriguez N, Burgner D, Stock SJ, Azad MB

Nature human behaviour2023

DOI: 10.1038/s41562-023-01522-y PMID: 36849590

Is in-utero exposure to cannabis associated with the risk of attention deficit with or without hyperactivity disorder? A cohort study within the Quebec Pregnancy Cohort.

Tchuente V, Sheehy O, Zhao JP, Gorgui J, Gomez YH, Berard A

BMJ open2022Senior author

DOI: 10.1136/bmjopen-2021-052220 PMID: 35940828

Maternal Schizophrenia and the Risk of a Childhood Chronic Condition

Vigod SN, Ray JG, Cohen E, Wilton AS, Saunders NR, Barker LC, Berard A, Dennis C-L, Holloway AC, Morrison K

Schizophrenia Bulletin20228 citationsOpen Access

DOI: 10.1093/schbul/sbac091 PMID: W4288096017

Protocol for a randomised trial evaluating a preconception-early childhood telephone-based intervention with tailored e-health resources for women and their partners to optimise growth and development among children in Canada: a Healthy Life Trajectory Initiative (HeLTI Canada)

Dennis C-L, Marini F, Dick JA, Atkinson S, Barrett J, Bell R, Berard A, Berger H, Brown HK, Constantin E

BMJ Open202132 citationsOpen Access

DOI: 10.1136/bmjopen-2020-046311 PMID: W3127363048

Risk of malformation after ondansetron in pregnancy: An updated systematic review and meta-analysis.

Picot C, Berard A, Grenet G, Ripoche E, Cucherat M, Cottin J

Birth defects research2020

DOI: 10.1002/bdr2.1705 PMID: 32420702

PREGTRIAL (Inclusion of PREgnant and lactatinG people in clinical TRIALs)

Principal investigatorCIHR2024Op. Grant: NWHRI: Innovation Fund - Healthcare implementation research

Principal investigators: Dayan, Natalie; Devereaux, Philip J; Bérard, Anick

Keywords: Accelerating Clinical Trials; Equity, Diversity And Inclusion; Implementation Science; Pregnancy And Lactation

$598,561

New statistical methods for population-based studies of time-varying drug exposures: development, validation, and real-world analyses of drug safety and effectiveness

Co-investigatorCIHR2021Project Grant

Principal investigators: Abrahamowicz, Michal M

Keywords: Absolute Risks; Biostatistics; Cumulative Effects; Drug Safety And Effectiveness; Exposure Measurement Errors; New Methods; Pharmacoepidemiology; Simulations; Time-Varying Exposures; Unmeasured Confounding

$481,950

The "Atrial FIBrillation in Pregnancy: assessing seveRe matErnal morbidity and anticoagulation strateGies" (AFIB-PREG) Study

Principal investigatorCIHR2021Project Grant

Principal investigators: Malhamé, Isabelle; Bérard, Anick; Bernatsky, Sasha R; Pilote, Louise

Keywords: Atrial Fibrillation; Cardiovascular Health; Maternal Mortality; Pregnancy; Pregnancy-Related Mortality; Severe Maternal Morbidity

$275,400

Enhancing CAN-AIM capacity to respond to drug safety and effectiveness queries

Principal investigatorCIHR2019DSEN team grants: MAGIC and CAN-AIM

Principal investigators: Bernatsky, Sasha R; Abrahamowicz, Michal M; Afif, Waqqas; Awadalla, Philip; Bérard, Anick; Buckeridge, David L; Hazlewood, Glen S; Hohl, Corinne M; Kowalec, Kaarina A; Moride, Yola; Moura, Cristiano S; Pilote, Louise; Tremlett, Helen L

Keywords: Comparative Effectiveness And Safety; Confounding Bias; Exposure Measurement Errors; Pharmacoepidemiology; Prospective Studies; Statistical Modelling

$2,550,000

New statistical methods for cohort studies of adverse effects of medications

Co-investigatorCIHR2016Project Grant

Principal investigators: Abrahamowicz, Michal M

Keywords: Biostatistics; Comparative Effectiveness; Competing Risks; Confounding Bias; Cumulative Effects; Exposure Measurement Errors; Pharmacoepidemiology; Simulations; Statistical Modeling; Time-Varying Exposure

$753,035

Assisted Reproductive Technologies and Folic Acid Supplementation: Gene-environment Interactions and Neurodevelopmental and Metabolic Outcomes in Children

Principal investigatorCIHR2015Environments, Genes and Chronic Disease - LOI

Principal investigators: Trasler, Jacquetta M; MacFarlane, Amanda; Bérard, Anick; Fraser, William D; Monnier, Patricia O; Nguyen, Tuong-Vi; Rozen, Rima; Seguin, Jean R; Walker, Claire-Dominique; Walker, Mark C; Weksberg, Rosanna; Wen, Shi Wu

Keywords: Assisted Reproductive Technologies; Cord Blood; Dna Methylation; Epigenomic Profiling; Folic Acid; Infertility; Metabolic Indices; Neurodevelopment; Placenta

Canadian Network for Advanced Interdisciplinary Methods for Prospective Studies of Drug Safety and Effectiveness

Principal investigatorCIHR2014Team Grant: DSEN Coll Centre for Prospective Studies -Comparative Effectiveness

Principal investigators: Abrahamowicz, Michal M; Bérard, Anick; Bernatsky, Sasha R; Hohl, Corinne M; Lacaille, Diane V; Levesque, Linda E; Levy, Adrian R; Moride, Yola; Pilote, Louise

Keywords: Comparative Effectiveness And Safety; Confounding Bias; Exposure Measurement Errors; Pharmacoepidemiology; Prospective Studies; Statistical Modeling

$1,242,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Anick Bérard

Research

Latest papers

Latest funding

Obstetric mode of delivery and risk of attention deficit hyperactivity disorder in children: insights from the Quebec pregnancy cohort.

Teratogenic Risk Impact Mitigation (TRIM): Development of Explicit Criteria to Facilitate Decisions Regarding Teratogenic Risk Mitigation Strategies.

Trends of antiseizure medication utilization among pregnant people in four Canadian provinces from 1998 to 2023; a study from the Canadian mother-child cohort active surveillance initiative (CAMCCO).

Causality assessment of adverse drug reaction: A narrative review to find the most exhaustive and easy-to-use tool in post-authorization settings.

Drug-related risk of hospital readmission in children with chronic diseases, a systematic review.

Changes in preterm birth and stillbirth during COVID-19 lockdowns in 26 countries.

Is in-utero exposure to cannabis associated with the risk of attention deficit with or without hyperactivity disorder? A cohort study within the Quebec Pregnancy Cohort.

Maternal Schizophrenia and the Risk of a Childhood Chronic Condition

Protocol for a randomised trial evaluating a preconception-early childhood telephone-based intervention with tailored e-health resources for women and their partners to optimise growth and development among children in Canada: a Healthy Life Trajectory Initiative (HeLTI Canada)

Risk of malformation after ondansetron in pregnancy: An updated systematic review and meta-analysis.

PREGTRIAL (Inclusion of PREgnant and lactatinG people in clinical TRIALs)

New statistical methods for population-based studies of time-varying drug exposures: development, validation, and real-world analyses of drug safety and effectiveness

The "Atrial FIBrillation in Pregnancy: assessing seveRe matErnal morbidity and anticoagulation strateGies" (AFIB-PREG) Study

Enhancing CAN-AIM capacity to respond to drug safety and effectiveness queries

New statistical methods for cohort studies of adverse effects of medications

Assisted Reproductive Technologies and Folic Acid Supplementation: Gene-environment Interactions and Neurodevelopmental and Metabolic Outcomes in Children

Canadian Network for Advanced Interdisciplinary Methods for Prospective Studies of Drug Safety and Effectiveness

Frequent collaborators

Anick Bérard

Cindy-Lee Dennis

Gideon Koren

Howard Berger

Gillian Hanley

Jon Barrett

Kellie Murphy

Rhonda Bell

Evelyn Constantin

Marcus Ng

Evelyn Constantin

Patricia Li

Marie-Ève Piché

Flavia Marini

Sarah Kimmins

Sherif Eltonsy

Kaarina Kowalec

Martine Puts

Magdalena Janus

Stephanie Atkinson

Katherine Morrison

Alison Holloway

Eyal Cohen

Joel Ray

Astrid Guttmann

Nicole Letourneau

Nazeem Muhajarine

Robyn Stremler

Stephen Scherer

Deborah Da Costa

Patricia Li

Karen Tu

Stephen Lye

Peter Szatmari

Kevin Thorpe

Marsha Campbell-Yeo